{"id":"https://openalex.org/W3201088151","doi":"https://doi.org/10.1093/rheumatology/keab689","title":"Incorporating gout guideline advice into urate reports is associated with reduced hospital admissions: results of an observational study","display_name":"Incorporating gout guideline advice into urate reports is associated with reduced hospital admissions: results of an observational study","publication_year":2021,"publication_date":"2021-09-13","ids":{"openalex":"https://openalex.org/W3201088151","doi":"https://doi.org/10.1093/rheumatology/keab689","mag":"3201088151","pmid":"https://pubmed.ncbi.nlm.nih.gov/34528071"},"language":"en","primary_location":{"id":"doi:10.1093/rheumatology/keab689","doi":"https://doi.org/10.1093/rheumatology/keab689","is_oa":false,"landing_page_url":"https://doi.org/10.1093/rheumatology/keab689","pdf_url":null,"source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5060808651","display_name":"Philip L. Riches","orcid":"https://orcid.org/0000-0003-3029-7098","observed_orcids":["https://orcid.org/0000-0003-3029-7098"]},"institutions":[{"id":"https://openalex.org/I1324252669","display_name":"NHS Lothian","ror":"https://ror.org/03q82t418","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1324252669"]},{"id":"https://openalex.org/I2800150677","display_name":"Western General Hospital","ror":"https://ror.org/009kr6r15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1324252669","https://openalex.org/I2800150677"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"Philip L Riches","raw_affiliation_strings":["Rheumatic Diseases Unit, Western General Hospital, NHS Lothian, Edinburgh"],"raw_orcid":"https://orcid.org/0000-0003-3029-7098","affiliations":[{"raw_affiliation_string":"Rheumatic Diseases Unit, Western General Hospital, NHS Lothian, Edinburgh","institution_ids":["https://openalex.org/I1324252669","https://openalex.org/I2800150677"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032013470","display_name":"Laura S. Downie","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117886","display_name":"Public Health Scotland","ror":"https://ror.org/023wh8b50","country_code":"GB","type":"government","lineage":["https://openalex.org/I1319760190","https://openalex.org/I4210117886"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Laura Downie","raw_affiliation_strings":["Public Health Scotland, Meridian Court, Glasgow"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Public Health Scotland, Meridian Court, Glasgow","institution_ids":["https://openalex.org/I4210117886"]}]},{"author_position":"last","author":{"id":null,"display_name":"Carol Thomson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324252669","display_name":"NHS Lothian","ror":"https://ror.org/03q82t418","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1324252669"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Carol Thomson","raw_affiliation_strings":["Laboratory Services, NHS Lothian, Edinburgh, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratory Services, NHS Lothian, Edinburgh, UK","institution_ids":["https://openalex.org/I1324252669"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5060808651"],"corresponding_institution_ids":["https://openalex.org/I1324252669","https://openalex.org/I2800150677"],"apc_list":{"value":2817,"currency":"GBP","value_usd":4225},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.18788367,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"61","issue":"5","first_page":"1885","last_page":"1891"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11139","display_name":"Gout, Hyperuricemia, Uric Acid","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11314","display_name":"Clinical Laboratory Practices and Quality Control","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3607","display_name":"Medical Laboratory Technology"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12664","display_name":"Clinical practice guidelines implementation","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gout","display_name":"gout","score":0.996999979019165},{"id":"https://openalex.org/keywords/serum-uric-acid","display_name":"serum uric acid","score":0.7609999775886536},{"id":"https://openalex.org/keywords/guideline-implementation","display_name":"guideline implementation","score":0.7509999871253967},{"id":"https://openalex.org/keywords/urate-lowering-therapy","display_name":"urate-lowering therapy","score":0.9279999732971191},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.8009999990463257},{"id":"https://openalex.org/keywords/allopurinol","display_name":"allopurinol","score":0.984000027179718},{"id":"https://openalex.org/keywords/febuxostat","display_name":"febuxostat","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nhs-lothian","display_name":"NHS Lothian","score":0.7540000081062317},{"id":"https://openalex.org/keywords/scotland","display_name":"Scotland","score":0.5920000076293945}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9657179713249207},{"id":"https://openalex.org/C2780402116","wikidata":"https://www.wikidata.org/wiki/Q133087","display_name":"Gout","level":2,"score":0.939349889755249},{"id":"https://openalex.org/C2780932893","wikidata":"https://www.wikidata.org/wiki/Q417296","display_name":"Febuxostat","level":4,"score":0.7350859642028809},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.7017067074775696},{"id":"https://openalex.org/C2780261098","wikidata":"https://www.wikidata.org/wiki/Q412486","display_name":"Allopurinol","level":2,"score":0.6993099451065063},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.6574134230613708},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5831722617149353},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5241256356239319},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.41298648715019226},{"id":"https://openalex.org/C2779721657","wikidata":"https://www.wikidata.org/wiki/Q49970","display_name":"Hyperuricemia","level":3,"score":0.41016829013824463},{"id":"https://openalex.org/C2779881121","wikidata":"https://www.wikidata.org/wiki/Q105522","display_name":"Uric acid","level":2,"score":0.3529515266418457},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.33284008502960205},{"id":"https://openalex.org/C194828623","wikidata":"https://www.wikidata.org/wiki/Q2861470","display_name":"Emergency medicine","level":1,"score":0.3312526345252991},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000069465","descriptor_name":"Febuxostat","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000493","descriptor_name":"Allopurinol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006073","descriptor_name":"Gout","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006073","descriptor_name":"Gout","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D006074","descriptor_name":"Gout Suppressants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006761","descriptor_name":"Hospitals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014527","descriptor_name":"Uric Acid","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/rheumatology/keab689","doi":"https://doi.org/10.1093/rheumatology/keab689","is_oa":false,"landing_page_url":"https://doi.org/10.1093/rheumatology/keab689","pdf_url":null,"source":{"id":"https://openalex.org/S183989336","display_name":"Rheumatology","issn_l":"1462-0324","issn":["1462-0324","1462-0332"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology","raw_type":"journal-article"},{"id":"pmid:34528071","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34528071","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Rheumatology (Oxford, England)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1534146221","https://openalex.org/W1994439773","https://openalex.org/W2022967311","https://openalex.org/W2049913374","https://openalex.org/W2061539881","https://openalex.org/W2099748786","https://openalex.org/W2099903944","https://openalex.org/W2121981931","https://openalex.org/W2122603195","https://openalex.org/W2128749468","https://openalex.org/W2131879291","https://openalex.org/W2164092313","https://openalex.org/W2801956772","https://openalex.org/W3104282256"],"related_works":["https://openalex.org/W2740790704","https://openalex.org/W2799903844","https://openalex.org/W4308683119","https://openalex.org/W2414092120","https://openalex.org/W3031110320","https://openalex.org/W2041883982","https://openalex.org/W3095366791","https://openalex.org/W4301148232","https://openalex.org/W2951076677","https://openalex.org/W4399443325"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,78,121,197,205,211,228],"impact":[4],"of":[5,11,71,119,123,155,176,187,214,234,241,249],"incorporating":[6],"treatment":[7],"guidance":[8],"into":[9,238],"reporting":[10,240],"urate":[12,25,57,242],"test":[13],"results.":[14],"METHODS:":[15],"Urate":[16],"targets":[17],"for":[18,172],"clinically":[19],"confirmed":[20],"gout":[21,47,72,120,177,188,252],"were":[22,48,59,169],"added":[23],"to":[24,84,103,157,227],"results":[26,243],"above":[27],"0.36":[28],"mmol/l":[29],"requested":[30],"after":[31,196],"September":[32],"2014":[33,62],"within":[34],"NHS":[35,105,126,158,254],"Lothian.":[36],"Scotland-wide":[37],"data":[38,55],"on":[39,56],"urate-lowering":[40],"therapy":[41],"prescriptions":[42],"and":[43,52,63,184,219],"hospital":[44],"admissions":[45,102,124,156],"with":[46,67,137,161,191,246,251,258],"analysed":[49,60],"between":[50,61],"2009":[51,167],"2020.":[53],"Local":[54],"tests":[58],"2015.":[64],"RESULTS:":[65],"Admissions":[66],"a":[68,88,98,116,138,166],"primary":[69,174],"diagnosis":[70,118,175],"in":[73,82,86,101,125,141,210,253,256],"Lothian":[74,127,159],"reduced":[75,128,171,247],"modestly":[76],"following":[77],"intervention":[79],"from":[80],"111/year":[81],"2010-2014":[83],"104/year":[85],"2015-2019,":[87],"non-significant":[89],"difference":[90,203],"(P":[91],"=":[92],"0.32).":[93],"In":[94],"contrast":[95],"there":[96,200],"was":[97,201,244],"significant":[99,139],"increase":[100,140,209],"remaining":[104,142,162],"Scotland":[106],"health":[107,144,261],"boards":[108,145,164],"(556/year":[109],"vs":[110,131,147,179],"606/year,":[111],"P":[112,133,149,181,193],"<":[113,134,150,182,194],"0.01).":[114,151],"For":[115],"secondary":[117,185],"number":[122],"significantly":[129,170],"(58/year":[130],"39/year,":[132],"0.01)":[135],"contrasting":[136],"Scottish":[143,163,260],"(220/year":[146],"290/year,":[148],"The":[152],"relative":[153,208],"rate":[154],"compared":[160,190],"using":[165],"baseline":[168],"both":[173],"(1.06":[178],"1.25,":[180],"0.001)":[183,195],"diagnoses":[186],"(0.64":[189],"1.4,":[192],"intervention;":[198],"however,":[199],"no":[202],"before":[204],"intervention.":[206],"A":[207],"prescription":[212],"rates":[213,248],"allopurinol":[215],"300":[216],"mg":[217,222],"tablets":[218,223],"febuxostat":[220],"120":[221],"may":[224],"have":[225],"contributed":[226],"improved":[229],"outcomes":[230],"seen.":[231],"CONCLUSION:":[232],"Incorporation":[233],"clinical":[235],"guideline":[236],"advice":[237],"routine":[239],"associated":[245],"admission":[250],"Lothian,":[255],"comparison":[257],"other":[259],"boards.":[262]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2021-09-27T00:00:00"}